Viewing Study NCT03076203


Ignite Creation Date: 2025-12-24 @ 7:45 PM
Ignite Modification Date: 2026-01-18 @ 6:28 AM
Study NCT ID: NCT03076203
Status: COMPLETED
Last Update Posted: 2025-04-29
First Post: 2017-02-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)
Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module